Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 360 Next >>

Filter Applied: platelet inhibiting drugs (Click to remove)

Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008

Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026

Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025

Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis
Stroke 56:3127-3137, Rodriguez-Caliemnes,A.,et al, 2025

Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009

Warfarin vs Aspirin for Symptomatic Intracranial Stenosis: Subgroup Analyses from WASID
Neurol 67:1275-1278, Kasner,S.E.,et al, 2006

Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005

Rescue Treatment with Abciximab in Acute Ischemic Stroke
Neurol 56:1585-1587, Lee,K.Y.,et al, 2001

Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000

Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987

Therapy of Ischemic Cerebrovascular Disease
Ann Int Med 93:742-756, Byer,J.A.,et al, 1980

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022

Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018

Insufficient Platelet Inhibition is Related to Silent Embolic Cerebral Infarctions After Coronary Angiography
Stroke 43:727-732, Kim,B.J.,et al, 2012

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage
Stroke 42:3661-3662, 3665, Steiner, T., 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracereral Hemorrhage
Stroke 42:3663-3664, 3665, Schulman, S., 2011

Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009

Prior Antiplatelet Use Dose Not Affect Hemorrhage Growth or Outcome After ICH
Neurol 72:1397-1402,1376, Sansing,L.H.,et al, 2009

Management of Carotid Stenosis
NEJM 3585:1617-1621, Sila,C.A., 2008

Regular Aspirin -Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death
Stroke 37:129-133,4, Saloheimo,P.,et al, 2006

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005

Antiplatelet Therapy Contributes to Acute Deterioration of Intracerebral Hemorrhave
Neurol 65:1000-1004, Toyoda,K.,et al, 2005

Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001

Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000

Stroke and Transient Ischaemic Attacks
JNNP 57:534-543, Humphrey,P., 1994

Guidelines for the Management of Patients with Acute Ischemic Stroke
Stroke 25:1901-1914, Adams,H.P.,et al, 1994

Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991

Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991

Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989

Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987

Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
NEJM 311:27-34, 100-1051984., Kistler,J.P.,et al, 1984

Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025

Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025

Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke
NEJM 393:1191-1201, Tao,C.,et al, 2025

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024

Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
JAMA Neurol 81:957-965, Navi,B.B.,et al, 2024

Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source
Neurol 103:e209949, Grannam,M.,et al, 2024

Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024

2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024

Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023

Antithrombotic Therapy in Patients with Cerebral Microbleeds or Cortical Siderosis, Is This Contraindicated?
Neurol 100:551-552, Schneck,M.J., &Biller,J., 2023

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
NEJM 388:2025-2095, Zi,W.,et al, 2023

Antiplatelet Therapy or Not for Asymptomatic/Incidental Lacunar Infarction
Stroke 54:1954-1959, Bilski.A.,et al, 2023

Perioperative Management of Anticoagulant and Antiplatelet Therapy
NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023

Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023

Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023

Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack
Ann Neurol 91:380-388, Wang, A.,et al, 2022

Oral Antiplatelet Therapy for Acute Ischemic Stroke
Stroke 53:e453-e454, Minhas, J.S.,et al, 2022



Showing articles 0 to 50 of 360 Next >>